Due to the COVID-19 pandemic, the ACP office is closed to the public as our staff work remotely. Click here to see how this impacts our programs and operations.

Schedule change – Naproxen sodium

May 3, 2011

Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).

← Previous ArticleNext Article →